Skip to main content
. 2019 Mar 4;12:19–26. doi: 10.2147/LRA.S193925

Table 4.

Percentage of patients developing clinically significant hemodynamic changes in both study groups

MD LD P-value

SV decrease >15% 23/33 (67%) 14/31 (45%) 0.047
MAP decrease >25% 12/33 (37%) 6/31 (19%) NS
SAP decrease >25% 16/33 (48%) 6/31 (19%) 0.014

Abbreviations: LD, low dose; MAP, mean arterial pressure; MD, medium dose; NS, not significant; SAP, systolic arterial pressure; SV, stroke volume.